GLP1R and type 2 diabetes mellitus: The disutility of daily versus weekly injectable treatment in T2DM has been estimated as − 0.023 in Scotland [17], versus − 0.032, − 0.037, or − 0.090 (GLP-1 RAs), or − 0.039, − 0.057, or − 0.095 (insulins) in the current study.